Today: 25 April 2026
Subscribe
Browse Category

Stock Market 13 December 2025 - 14 December 2025

Nu Holdings (NU) Stock Update: Brazil Banking-License Push, Colombia’s 4M Milestone, and Key Catalysts for the Week Ahead (Updated Dec. 12, 2025)

Nu Holdings (NU) Stock Update: Brazil Banking-License Push, Colombia’s 4M Milestone, and Key Catalysts for the Week Ahead (Updated Dec. 12, 2025)

Nu Holdings (NYSE: NU) closed Dec. 12, 2025, at about $16.90, recovering after a 5.38% drop on Dec. 5 and ending the week up 1.2%. The company disclosed plans to seek a full banking license in Brazil by 2026, citing regulatory changes. Bloomberg reported Nu may consider acquiring a small Brazilian bank, with Banco Digimais named as a possible target. Nubank serves over 110 million customers in Brazil.
14 December 2025
··
Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Destiny Tech100 (DXYZ) surged 38% in five sessions, closing Dec. 12 at $37.96 on heavy volume, as speculation over a potential SpaceX IPO drew investor interest. The closed-end fund, which holds late-stage private tech firms, traded far above its net asset value. Friday’s volume hit 7.58 million shares, with pre-market activity also spiking. DXYZ’s price often moves on sentiment rather than underlying portfolio value.
14 December 2025
··
Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Milestone Pharmaceuticals said late Friday the FDA approved CARDAMYST (etripamil) as the first self-administered nasal spray for PSVT. MIST shares closed down 18.3% at $2.41 after volatile trading and heavy volume, but rebounded modestly after hours. CARDAMYST is expected in pharmacies in Q1 2026. In a Phase 3 trial, 64% of patients converted to normal rhythm within 30 minutes, compared to 31% on placebo.
14 December 2025
··
MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

MercadoLibre closed at $2,015.89 on Dec. 12 after a volatile week marked by a 5% drop Wednesday and a rebound. The company announced a pilot with Agility Robotics to deploy humanoid robots in its Texas warehouse, with possible expansion to Latin America. MercadoLibre also completed a $750 million bond offering, its first since reaching investment grade.
14 December 2025
··
NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy closed at $81.65 on Dec. 12, down 1.8% from the prior week. Shares fell sharply early in the week before rebounding, following news of new Google Cloud and Meta energy agreements. The company raised its 2025–2026 earnings guidance and analysts issued fresh price targets.
14 December 2025
····
DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

DoorDash shares closed Friday at $227.49, up 1.32% for the day and capping a volatile week marked by a sharp midweek drop after Amazon expanded same-day grocery delivery to over 2,300 U.S. cities. The stock fell 4.2% Wednesday before rebounding, finishing the week with a 7% trading range. DoorDash is up about 35% year-to-date but remains 20% below its October high.
13 December 2025
·
Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Nike shares closed Friday at $67.47, down 0.40% on the day but up 6.2% from Monday’s close after a volatile week. The stock rebounded midweek as the Federal Reserve cut rates by 25 basis points. Nike also named Venkatesh Alagirisamy as its first chief operating officer, restructuring senior leadership ahead of its Q2 earnings report on Dec. 18.
13 December 2025
···
Interactive Brokers (IBKR) Stock This Week: Stablecoin Funding, Global Expansion, and What to Watch Next Week (Updated Dec. 12, 2025)

Interactive Brokers (IBKR) Stock This Week: Stablecoin Funding, Global Expansion, and What to Watch Next Week (Updated Dec. 12, 2025)

Interactive Brokers closed Friday at $64.15, down 2.9% after a volatile session that saw shares swing between $66.00 and $62.58. The company began allowing some U.S. retail clients to fund brokerage accounts with stablecoins, enabling direct transfers from crypto wallets. The move comes as investors weigh shifting U.S. rate policy and the firm's global expansion efforts.
13 December 2025
··
HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Healthcare shares closed at $484.77 on Friday, ending the week nearly unchanged after a sharp 4% drop Wednesday on heavy volume. The midweek decline followed reports of possible Medicare reimbursement cuts under discussion in Congress. HCA remains below its late-November record high of $515.85. Trading volatility this week drew renewed focus to policy risk for hospital operators.
13 December 2025
·
Lockheed Martin (LMT) Stock: This Week’s Rally, Fresh F-35 Headlines, and the Week-Ahead Outlook (Updated 12.12.2025)

Lockheed Martin (LMT) Stock: This Week’s Rally, Fresh F-35 Headlines, and the Week-Ahead Outlook (Updated 12.12.2025)

Lockheed Martin shares closed at $480.25 on Friday, Dec. 12, 2025, capping a nine-session winning streak despite a broader market decline. The stock rose 6.2% over the week. Switzerland announced it will cut its planned F-35 jet purchase to stay within budget, raising questions about future order volumes. Trading volume reached about 1.38 million shares.
13 December 2025
···
Starbucks Stock Forecast: SBUX News, This Week’s Price Action, and the Week Ahead Updated Dec. 12, 2025

Starbucks Stock Forecast: SBUX News, This Week’s Price Action, and the Week Ahead Updated Dec. 12, 2025

Starbucks shares closed Friday at $85.35, up slightly from last week after rebounding from a Tuesday low of $82.28. The stock remains 28.6% below its 52-week high. A workers’ strike expanded to 34 U.S. cities this week, with over 3,800 employees participating. Starbucks said fewer than 1% of its U.S. stores were affected by the strike.
13 December 2025
··
CME Group Inc. Stock (NASDAQ: CME) This Week: Shares Rebound on Strong Volume Data, SEC Clearing-House Greenlight — Week Ahead Outlook (Updated Dec. 12, 2025)

CME Group Inc. Stock (NASDAQ: CME) This Week: Shares Rebound on Strong Volume Data, SEC Clearing-House Greenlight — Week Ahead Outlook (Updated Dec. 12, 2025)

CME Group shares closed at $273.55 on Friday, Dec. 12, up 0.42% for the day and about 1% for the week after rebounding from a midweek low. November average daily volume reached 33.1 million contracts, up 10% year-over-year, marking the company’s second-highest monthly total. The SEC approved CME’s new securities clearing house, set to launch in Q2 2026.
13 December 2025
·
Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Vertex Pharmaceuticals shares closed at $452.04 Friday, up 2.26% for the week after rebounding from early losses. The move followed new pediatric data for CASGEVY, showing children ages 5–11 with sickle cell disease remained crisis-free for at least 12 months. Vertex plans global regulatory submissions in 2026. One beta thalassemia patient died from pre-transplant chemotherapy complications.
13 December 2025
··
Southern Copper (SCCO) Stock This Week: Record-High Copper, Analyst Targets, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Southern Copper (SCCO) Stock This Week: Record-High Copper, Analyst Targets, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Southern Copper Corporation closed Friday at $142.41, down 3.54% after shares swung between $141.84 and $149.75. The move tracked copper prices, which neared $12,000/ton this week before retreating. Analyst sentiment remains cautious, with most 12-month targets below the current share price. Southern Copper reported record quarterly results and low cash costs in Q3.
13 December 2025
·
ConocoPhillips (COP) Stock: This Week’s Moves, Fresh Alaska Lawsuit News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

ConocoPhillips (COP) Stock: This Week’s Moves, Fresh Alaska Lawsuit News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

ConocoPhillips closed at $95.54 on Dec. 12, up 2.86% from Monday, after a volatile week marked by falling oil prices and a new Alaska lawsuit challenging its exploration program. Brent crude settled at $61.12 per barrel, down about 4% for the week. COP remains roughly 10% below its 52-week high of $106.20. Analyst price targets and legal headlines added to trading pressure.
13 December 2025
··
1 … 970 971 972 973 974 … 1,388

Stock Market Today

  • Breakwave Tanker Shipping ETF Surges 600% Amid U.S.-Iran War Disruptions
    April 25, 2026, 9:02 AM EDT. The Breakwave Tanker Shipping ETF (BWET) has risen over 600% this year, significantly outperforming crude oil's approximately 60% gain amid the U.S.-Iran conflict. This ETF tracks crude oil tanker freight rates, which have soared due to disruptions in key maritime routes like the Strait of Hormuz. Experts note investors are now betting on higher shipping costs and energy infrastructure instead of just oil prices. BWET's growth signals a shift in focus toward the logistics of energy transport, with freight futures reacting sharply to geopolitical risks. The ETF, launched in May 2023 with a $30 million portfolio, highlights a broader market move to profit from energy volatility related to global trade disruptions.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 25.04.2026

25 April 2026
LIVEMarkets rolling coverageStarted: April 25, 2026, 12:00 AM EDTUpdated: April 25, 2026, 9:13 AM EDT Breakwave Tanker Shipping ETF Surges 600% Amid U.S.-Iran War Disruptions April 25, 2026, 9:02 AM EDT. The Breakwave Tanker Shipping ETF (BWET) has risen over **600%** this year, significantly outperforming crude oil's approximately **60%** gain amid the U.S.-Iran conflict. This ETF tracks **crude oil tanker freight rates**, which have soared due to disruptions in key maritime routes like the Strait of Hormuz. Experts note investors are now betting on higher **shipping costs** and **energy infrastructure** instead of just oil prices. BWET's growth signals a shift
LightPath Technologies Stock Just Hit a 52-Week High. Here’s Why LPTH Is Back in Focus

LightPath Technologies Stock Just Hit a 52-Week High. Here’s Why LPTH Is Back in Focus

25 April 2026
LightPath Technologies shares closed up 10.05% at $16.09 in Orlando Friday, after hitting $16.53 and surpassing recent analyst targets. Trading volume jumped to 6.35 million shares. The company reported a $97.8 million backlog and second-quarter revenue of $16.4 million, up 120% from a year earlier. Recent orders and investor focus center on defense optics and infrared camera systems.
Wolfspeed Stock Jumps 13% Before May 5 Earnings Test

Wolfspeed Stock Jumps 13% Before May 5 Earnings Test

25 April 2026
Wolfspeed shares surged 13.36% to $31.23 on Friday, with trading volume hitting 8.4 million shares ahead of its May 5 earnings report. The chipmaker recently cut its debt by about $97 million and lowered annual interest expense by $62 million after refinancing in March. Wolfspeed reported a $151 million net loss last quarter and expects negative gross margins to continue.
Go toTop